Research shows weight-loss drugs may also reduce cancer risk

Live updates

1. 5h ago

   GLP-1 Drugs Linked to Lower Cancer Risk and Slower Progression

   Early research suggests GLP-1 medications like Ozempic and Mounjaro can reduce the odds of developing certain cancers. Data indicates these drugs may also slow the spread of obesity-related cancers. Experts state that more research is required to confirm these findings.

   What's confirmed:

   • GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound may lower the risk of developing certain cancers.
   • Research suggests these medications may slow cancer progression in some patients.

   Still unconfirmed:

   • GLP-1 receptor agonists may reduce metastatic progression specifically in lung, breast, colorectal, and liver cancers.
   confidence 80%
2. 3d ago

   GLP-1 Weight-Loss Drugs Linked to Lower Cancer Risks

   Research indicates GLP-1 medications like Ozempic and Wegovy may reduce the risk of several obesity-related cancers. Studies show significant risk reductions for colorectal, pancreatic, and breast cancers. Some data suggests these drugs may also improve survival rates and slow cancer progression.

   What's confirmed:

   • GLP-1 medications are linked to a decreased risk of obesity-related cancers, including colorectal, pancreatic, and endometrial types.
   • Women taking GLP-1 drugs had a lower risk of breast cancer in a study of more than 110,000 women.
   • GLP-1 drugs are associated with a 30% lower risk of breast cancer in women.
   • The American Society of Clinical Oncology reports that GLP-1 medications may help prevent cancer.

   Still unconfirmed:

   • GLP-1 RA use is linked to improved survival in patients with cancer.
   confidence 90%